FDA Classifies Two Field Actions Related to HeartWare HVAD System as Class 1 Recalls
DUBLIN - Sept. 30, 2016 - Medtronic plc (NYSE:MDT) announced today that two previously communicated global voluntary recalls related to the HeartWare International (HeartWare) HVAD® System have been classified ...